The global cell isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9billion in 2020, at a CAGR of 16.8% during the forecast period. Market growth is driven by factors The growing investments in personalized medicine can primarily be attributed to the growing demand for advanced treatments with minimal side-effects and the rising prevalence of diseases such as cancer. With the rising focus on the development of personalized medicine, the number of personalized medications available in the market has steadily increased over the last decade, and this trend is expected to continue in the coming years.
The consumablesaccounted for the highest growth rate in thecell isolationmarket, by productduring the forecast period Based on product, the cell isolation market is segmented into consumables and instruments.The consumables segment accounted for the largest share in the cell isolation market in the forecasted period.
The increasing investments by companies to develop technologically advanced products as well as the repetitive use of consumables as compared to instruments are the major factors driving the growth of this segment.
Human cells segment accounted for the highest CAGR Based on cell type, the cell isolation market is segmented into human cells and animal cells.The human cells segment accounted for the largest share of the global cell isolation market in the forecasted period.
The increasing investments by public and private organizations for research on human cells, growing application areas of human stem cells, and the high and growing incidence of diseases such as cancer are the major factors driving this segment’s growth.
Biotechnology and biopharmaceutical companiessegment accounted for the highest CAGR The cell isolation market is segmented into hospitals and diagnostic laboratories, biotechnology and biopharmaceutical companies, research laboratories and institutes, and other end users based on end users.In 2019, the biotechnology and biopharmaceutical companies segment accounted for the largest share.
The widespread adoption of advanced instruments in cell-based experiments and cancer research in biotechnology and biopharmaceutical companies, as well as the increasing number of R&D facilities globally are the major factors driving this segment’s growth.
Asia Pacific: The fastest-growing regioncell isolation market The global cell isolation market is segmented into North America, Europe, Asia Pacific, and Rest of the world.The Asia Pacific region is projected to register the highest CAGR during the forecast period.
Growth in this region is expected to be centered on China and Japan. Factors such as the expansion by key market players in emerging Asian countries and the increasing trend of pharmaceutical outsourcing to Asian countries like India and China are driving the growth of the cell isolation market in this region.
The primary interviews conducted for this report can be categorized as follows: • By Company Type: Tier 1 - 20%, Tier 2 - 45%,and Tier 3 -35% • By Designation: C-level - 30%, D-level - 20%, and Others - 50% • By Region: North America -35%, Europe - 24%, Asia Pacific - 25%, Rest of the world– 16%
Lits of Companies Profiled in the Report: • Thermo Fisher Scientific, Inc. (US) • Becton, Dickinson and Company Limited (US) • Beckman Coulter Inc. (US).Merck KGaA (Germany) • Terumo BCT (Japan), GE Healthcare (US) • Bio- Rad Laboratories Inc. (US) • Corning Inc. (US) • Roche Diagnostics (Switzerland) • Alfa Laval (Sweden) • Miltenyl Biotech (Germany) • pluriSelect Life Science (Germany) • STEMCELL Technologies Inc. (Canada) • Akadeum Life Sciences, Inc (US) • Bio- Techne (US), Bio Legend (US) • Invent Biotechnologies (US)
Research Coverage: This report provides a detailed picture of the global cell isolation market.It aims at estimating the size and future growth potential of the market across different segments, such as product, celltype, cell source, technique, application, end user, and region.
The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell isolation market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, trends, and opportunities.
Our reports have been used by over 10K customers, including:
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Portable Patient Isolation Market Report
The global portable patient isolation market by revenue is expected to grow at a CAGR of 13% during the period 2021–2026.
The demand for transport rooms and pods is likely to observe an impetus...
The anti-money laundering solution market was valued at US$ 1,503.99 million in 2019 and is projected to reach US$ 5,866.51 million by 2027; it is expected to grow at a CAGR of 16.2% from 2020 to 2027. Transaction monitoring is a crucial procedure and key control in anti-money laundering (AML) and countering the financing of terrorism (AML/CFT)...
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
The global cancer cachexia market was valued at USD 2,256.35 million in 2020, and it is expected to reach USD 2,974.49 million by 2026, registering a CAGR of 4.47% during the forecast period. The outbreak of COVID-19 impacted the cancer cachexia market, as hospitals and healthcare services were significantly reduced due to social distancing...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global IV and Oral Iron Drugs Market Report
The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021–2026.
The global IV and oral iron drugs market is expected to grow due to the prevalence...
The propelling factors for the growth of the apheresis market include the increasing number of diseases, a rise in the demand for blood components and associated safety, technological advancement in the development of new apheresis techniques, and rise in the reimbursement policies and funding for apheresis procedures. With the increasing...
The global dental impression systems market is projected to reach USD 1.9 billion by 2025 from USD 1.3 billion in 2020, at a CAGR of 7.7% during the forecast period. The growth in this market is driven by rising incidence of dental diseases, increasing demand for cosmetic dentistry, and growing dental tourism in emerging markets. However,...
The genetic toxicology testing market is projected to reach USD 2.0 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 10.2%. Growth in this market is primarily driven by increased pharmaceutical research activities, opposition to animal testing, and R&D on early toxicity detection. The increasing focus on drug discovery and personalized...
Certain factors that are driving the market growth include rising healthcare expenditure, growing burden of chronic diseases and advances in drug discovery and development. The burden of chronic diseases is increasing worldwide. According to WHO, chronic diseases have always been a massive global challenge, and they account for approximately...
The Near Infrared Imaging Market was valued at US$ million 395.14 in 2019 and is projected to reach US$ 543.24 million by 2027; it is expected to grow at a CAGR of 4.2% from 2020 to 2027. The growth of the Near Infrared Imaging market is mainly attributed to factors such as rising number of surgical procedures worldwide, and advantages...
Research And Development
Surgical Procedures Performed
Chronic Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.